TA Associates Is Said to Delay OmniActive Sale on Tariff Concern
NegativeFinancial Markets

TA Associates is postponing the sale of its majority stake in OmniActive Health Technologies due to concerns over how US tariffs might affect the business. This delay highlights the ongoing uncertainty in international trade and its potential impact on investments, particularly in the health sector. Stakeholders are closely watching how these tariff issues will unfold, as they could influence future business decisions and market dynamics.
— Curated by the World Pulse Now AI Editorial System